← ANALYSTS · TIPRANKS
Justin Keywood · Stifel Nicolaus
Hits
51%
247 of 481 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+0.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
2
Buy / hold / sell: 2 / 0 / 0
Upside of the analyst’s targets
+89.9%
Average over 2 current targets, to the last price
The market’s answer to the ratings
—
No upgrade, downgrade or target change with a known move yet
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Aug 5on TipRanks Aug 9 10:15 | WELLSPYWelltower · $167B | Reiterated | Buy | $5.96 | −97.5% | +2.7%next day −0.4% · 5 days −2.9% | ↗ |
| May 21on TipRanks May 24 14:15 | NGENNervGen Pharma · $205M | Reiterated | Buy | $6.00 | +277.4% | −1.8%next day −43.9% · 5 days −45.6% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗